Lead sponsor
Zomagen Biosciences Ltd.
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
176
Total enrollment
14
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Completed
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in ObesityBMI 30-42Ph 2Completed176